Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
DSGN Quote, Financials, Valuation and Earnings
Last price:
$4.01
Seasonality move
:
-15.63%
Day range:
$3.95 - $4.34
52-week range:
$2.60 - $7.77
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.00x
Volume:
90.6K
Avg. volume:
97.7K
1-year change:
-9.87%
Market cap:
$228.2M
Revenue:
--
EPS (TTM):
-$0.99
Earnings Data
Next earnings date for DSGN
Aug 05
2025
Most recent earnings per share
-$0.31
Missed by $0.03
(May 7/2025)
Consensus Estimate
-$0.28
(May 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
DSGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.34 | -- |
| 08/05/2025 | Q2 | -- | -- | -- | -$0.33 | -- |
| 05/07/2025 | Q1 | -- | -- | -$0.31 | -$0.28 | -$0.03 |
| 03/10/2025 | Q4 | -- | -- | -$0.24 | -$0.27 | $0.03 |
| 11/07/2024 | Q3 | -- | -- | -$0.23 | -$0.24 | $0.01 |
| 08/05/2024 | Q2 | -- | -- | -$0.21 | -$0.23 | $0.02 |
| 05/08/2024 | Q1 | -- | -- | -$0.20 | -$0.26 | $0.06 |
| 03/19/2024 | Q4 | -- | -- | -$0.21 | -$0.32 | $0.11 |
| 11/13/2023 | Q3 | -- | -- | -$0.28 | -$0.42 | $0.14 |
| 08/14/2023 | Q2 | -- | -- | -$0.36 | -$0.40 | $0.04 |
| 05/09/2023 | Q1 | -- | -- | -$0.35 | -$0.35 | -- |
| 03/14/2023 | Q4 | -- | -- | -$0.31 | -$0.35 | $0.04 |
| 11/03/2022 | Q3 | -- | -- | -$0.32 | -$0.29 | -$0.03 |
| 08/08/2022 | Q2 | -- | -- | -$0.27 | -$0.25 | -$0.02 |
| 05/09/2022 | Q1 | -- | -- | -$0.24 | -$0.22 | -$0.02 |
| 03/10/2022 | Q4 | -- | -- | -$0.20 | -$0.23 | $0.03 |
| 11/09/2021 | Q3 | -- | -- | -$0.21 | -$0.13 | -$0.08 |
| 08/09/2021 | Q2 | -- | -- | -$0.14 | -$0.22 | $0.08 |
| 05/10/2021 | Q1 | -- | -- | -$0.31 | -$0.09 | -$0.22 |
| 12/31/2020 | Q4 | -- | -- | -$0.07 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.05 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.02 | -- | -- |
Design Therapeutics Earnings Questions
-
How Much did Design Therapeutics Generate in Revenue Last Quarter?
Design Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Design Therapeutics Beat Earnings Last Quarter?
Design Therapeutics announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.28 per share.
-
Is Design Therapeutics Profitable?
Design Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Design Therapeutics EPS Next Year?
Design Therapeutics's earnings are forecast to decrease from -$0.88 per share to -$0.90 per share next year representing a decrease of -51.14%.
-
When is Design Therapeutics's Earnings Date?
Design Therapeutics's next earnings date is August 5, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.16% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 13.24% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 2.14% over the past day.
